VGI Medical, LLC
USPTO PatentsView assignee record - 8 granted patents across 2 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, VGI ranks #33,809 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 2 technology areas.
- #33,809
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (40.9/100)
- 13.9
- avg claims per patent
- +33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R33809 · US Corporation #33,809 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #33,809/49,997
- PHOTO-FINISH Verastem
- CPC-NARROW A61B · 2 areas
- INNOV-PAR 40.9/100
- CLAIMS-RICH 13.9 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Verastem, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How VGI’s 40.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around VGI
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- VGI Medical · this assignee
VGI Medical · this assignee
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows VGI's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for VGI?
Each dot is one of VGI’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). VGI’s own 13.9 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where VGI's grants concentrate
VGI Medical, LLC is a focused PatentsView assignee: 2 CPC subclasses with 75% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2016. By volume, VGI sits between Verastem, Inc. and Vidaa (NETHERLANDS) International Holdings B.V. Vidaa.
VGI's three-year grant acceleration
VGI Medical, LLC shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at VGI's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Verastem
Verastem, Inc.
8 patents
- Verve Therapeutics
Verve Therapeutics, Inc.
8 patents
- Vestre AS
Vestre AS
8 patents
- VF
VF Corporation
8 patents
- VI Systems
VI Systems GmbH
8 patents
- Vianai Systems
Vianai Systems, Inc.
8 patents
- Vibes Audio
Vibes Audio LLC
8 patents
- Vidaa (Netherland…
Vidaa (NETHERLANDS) International Holdings B.V. Vidaa
8 patents
- VGI Medical ◀
VGI Medical, LLC
8 patents
What this shows VGI holds 8 patents at rank #33,770, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near VGI
By rank, the assignees closest to #33,770 in granted patent volume.
- Verastem, Inc. #33,766 · 8 patents
- Verve Therapeutics, Inc. #33,767 · 8 patents
- Vestre AS #33,768 · 8 patents
- VF Corporation #33,769 · 8 patents
- VI Systems GmbH #33,771 · 8 patents
- Vianai Systems, Inc. #33,772 · 8 patents
- Vibes Audio LLC #33,773 · 8 patents
- Vidaa (NETHERLANDS) International Holdings B.V. Vidaa #33,774 · 8 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in VGI's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
VGI's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
| 2019 | 1 | 12.5% |
| 2023 | 4 | 50.0% |
| 2025partial year | 1 | 12.5% |
Which technologies does VGI Medical, LLC patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
VGI Medical, LLC's patent record in context - here's where to go next.
- VGI Medical, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 75% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #33,809 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare VGI Medical, LLC against Verastem, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.